Preliminary studies on the elimination of 3-H doxycycline in normal subjects and in patients with severely impaired renal function.
D000284:Administration, Oral; D000818:Animals; D001702:Biopharmaceutics; D002214:Capsules; D004285:Dogs; D004304:Dosage Forms; D004318:Doxycycline / Q000008:administration & dosage / Q000097:blood / Q000378:metabolism* / Q000652:urine; D005243:Feces / Q000032:analysis; D005470:Fluorometry; D006207:Half-Life; D006801:Humans; D007676:Kidney Failure, Chronic / Q000378:metabolism*; D014316:Tritium
D002214:Capsules; D004304:Dosage Forms; D014316:Tritium; D004318:Doxycycline